Karin Rodland

Last updated
Karin D. Rodland
Born1949
Alma mater Syracuse University
Known forcancer cell biology
Scientific career
Fields proteomics, systems biology
Institutions Pacific Northwest National Laboratory
Oregon Health & Science University
Thesis A comparative study of thermoregulatory responses to acute heat stress in three rodent species.  (1974)

Karin Dorinda Norlin Rodland (born 1949) is an American cancer cell biologist. She is a professor emeritus at Oregon Health and Science University.

Contents

Education

Rodland earned an A.B. from Hood College in 1970, and a PhD in biology from Syracuse University in 1974. She also completed her post-doctoral research at Syracuse with a National Cancer Institute Public Health Service Research Service Award. [1]

Career

Rodland began her academic career at Reed College in 1979, then Oregon Health and Science University School of Medicine in 1985. She was named a laboratory fellow at the U.S. Pacific Northwest National Laboratory, and a professor emeritus in Cell, Developmental and Cancer Biology, at Oregon Health and Science University School of Medicine. [1] [2] She retired in June 2020. [3]

Rodland serves on the board of directors for the U.S. Human Proteome Organization, [4] the editorial board of Cancer Biomarkers [5] and Cancer Genomics and Proteomics, [6] and on the Leadership Development Committee of the Federation of American Societies for Experimental Biology. [7] She was appointed to the Board of Directors of the Andy Hill Cancer Research Endowment (CARE) Fund by Washington State Governor Jay Inslee in 2022 [8] and served through June 2024.

Awards

Selected publications

References

  1. 1 2 "CDCB Emeritus Faculty | OHSU". www.ohsu.edu. Retrieved 2022-06-13.
  2. "Karin Rodland Ph.D. | OHSU People | OHSU". www.ohsu.edu. Retrieved 2022-06-13.
  3. "A Career in Cancer Research Ends with Long-Awaited Experiments | PNNL". www.pnnl.gov. Retrieved 2022-06-13.
  4. "US HUPO - Board of Directors". www.ushupo.org. Retrieved 2022-06-11.
  5. "Cancer Biomarkers". IOS Press. Retrieved 2022-06-13.
  6. "Editorial Board of Cancer Genomics & Proteomics 2022 | Cancer Genomics & Proteomics". cgp.iiarjournals.org. Archived from the original on 2022-01-26. Retrieved 2022-06-13.
  7. "LDC Committee Home". ffvp.memberclicks.net. Retrieved 2022-06-11.
  8. "Recent Appointments: Governor Jay Inslee". www.governor.wa.gov. Retrieved 2022-06-11.
  9. "News". CARE Fund. Retrieved 2022-06-13.
  10. "Recognized Leader and Mentor Dr. Robert J. Mayer Receives Distinguished Achievement Award". Default Digital Object Group. 2019-05-13. doi:10.1200/adn.19.190221. S2CID   240684358 . Retrieved 2022-06-11.
  11. 1 2 "Awards | Northwest Ninety-Nines | Organization of Women Pilots". nw99s.org. Retrieved 2022-06-11.
  12. "AAAS Members Elected as Fellows | American Association for the Advancement of Science". www.aaas.org. Retrieved 2022-06-11.
  13. "PNNL: Karin Rodland selected as Laboratory Fellow". www.pnnl.gov. Retrieved 2022-06-11.
  14. Mass spectometry and biomarker development. Karin D. Rodland. Amsterdam: IOS Press. 2005. ISBN   1-58603-461-8. OCLC   156786281.{{cite book}}: CS1 maint: others (link)
  15. Zhang, Hui; Liu, Tao; Zhang, Zhen; Payne, Samuel H.; Zhang, Bai; McDermott, Jason E.; Zhou, Jian-Ying; Petyuk, Vladislav A.; Chen, Li; Ray, Debjit; Sun, Shisheng (2016). "Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer". Cell. 166 (3): 755–765. doi:10.1016/j.cell.2016.05.069. PMC   4967013 . PMID   27372738.
  16. Vasaikar, Suhas; Huang, Chen; Wang, Xiaojing; Petyuk, Vladislav A.; Savage, Sara R.; Wen, Bo; Dou, Yongchao; Zhang, Yun; Shi, Zhiao; Arshad, Osama A.; Gritsenko, Marina A. (2019). "Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities". Cell. 177 (4): 1035–1049.e19. doi:10.1016/j.cell.2019.03.030. PMC   6768830 . PMID   31031003.
  17. Systems biology of biomarkers. Karin D. Rodland. IOS Press. 2010. ISBN   978-1-60750-584-6. OCLC   669738858.{{cite book}}: CS1 maint: others (link)